Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration

Life Sci. 1998;63(24):2147-55. doi: 10.1016/s0024-3205(98)00495-0.

Abstract

At 0.5-12 h after oral administration of tamsulosin (2.3 micromol/kg) in rats, there was a significant decrease in specific [3H]prazosin binding in the prostate as compared to the control value. The greater decrease occurred in the submaxillary gland. The effect of tamsulosin was mainly due to a marked reduction of [3H]prazosin binding sites (Bmax) rather than to an increase in the dissociation constant (Kd). In contrast, there was only a slight decrease or no change in the [3H]prazosin binding in the spleen, heart, and cerebral cortex of tamsulosin-administered rats at 0.5-12 h. Oral administration of terazosin (21.7 micromol/kg) significantly increased Kd values for [3H]prazosin binding with little effect on Bmax values in the rat prostate at 3 and 6 h. The greater increases in Kd values were observed in the submaxillary gland, spleen and heart at 0.5-12 h. Terazosin had a slight effect on Kd values for the cerebral cortical [3H]prazosin binding. Tamsulosin was absorbed rapidly after oral administration at a dose of 2.3 micromol/kg in rats, and at 6 h, plasma concentration decreased markedly to approximately one-twentieth of the 0.5 h peak level. alpha1-Adrenoceptor occupancy was estimated as a percentage of decrease in Bmax values for [3H]prazosin binding in tissues of tamsulosin-treated rats compared with control rats. The alpha1-adrenoceptor occupancy by tamsulosin in the prostate and submaxillary gland occurred rapidly in parallel with the rise in plasma concentration of tamsulosin, and lasted for over 12 h despite the marked decrease in plasma concentration. Consequently, it is suggested that tamsulosin produces more selective and sustained occupancy in vivo of alpha1-adrenoceptors in the submaxillary gland and prostate of rats than in other tissues.

MeSH terms

  • Administration, Oral
  • Adrenergic alpha-Antagonists / administration & dosage
  • Adrenergic alpha-Antagonists / blood
  • Adrenergic alpha-Antagonists / metabolism*
  • Animals
  • Male
  • Prazosin / administration & dosage
  • Prazosin / analogs & derivatives
  • Prazosin / metabolism
  • Prazosin / pharmacology
  • Protein Binding
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-1 / metabolism*
  • Sulfonamides / administration & dosage
  • Sulfonamides / blood
  • Sulfonamides / metabolism*
  • Tamsulosin
  • Tissue Distribution

Substances

  • Adrenergic alpha-Antagonists
  • Receptors, Adrenergic, alpha-1
  • Sulfonamides
  • Terazosin
  • Tamsulosin
  • Prazosin